Immunoconjugate Therapy of Hematologic Malignancies - Cancer Treatment and Research 68 (Paperback)
  • Immunoconjugate Therapy of Hematologic Malignancies - Cancer Treatment and Research 68 (Paperback)
zoom

Immunoconjugate Therapy of Hematologic Malignancies - Cancer Treatment and Research 68 (Paperback)

(editor), (editor)
£129.99
Paperback 205 Pages / Published: 25/09/2012
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
The hybridoma technique for producing monoclonal antibodies developed by Drs. Kohler and Millstein in 1975 revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value, and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of Cancer Treatment and Research explores the current state of the art of immunoconjugate therapy of hematologic malignancies. The first chapter, authored by Drs. Rosen and Kuzel, reviews the current status of radioimmunotherapy of lymphoma. Results of clinical investigations utilizing radiolabeled immunoconjugates in B-cell lymphomas, T-cell lym- phomas, and Hodgkin's disease are discussed. In addition, obstacles to effective antibody therapy are highlighted and toxicities are summarized. Chapter 2, written by Drs. Sgouros and Scheinberg, critiques the treat- ment of leukemia with radiolabeled monoclonal antibodies. In this chapter, the unique features of leukemia that make it particularly suitable for radio- immunotherapy are discussed, an overview of selected clinical trials is presented, and a treatment planning approach to radioimmunotherapy in- corporating biologic and physical parameters is reviewed.

Publisher: Springer-Verlag New York Inc.
ISBN: 9781461363439
Number of pages: 205
Weight: 349 g
Dimensions: 235 x 155 x 12 mm
Edition: Softcover reprint of the original 1st ed. 199

You may also be interested in...

C List
Added to basket
£10.99
Paperback
Cancer: A Very Short Introduction
Added to basket
Beating Cancer with Nutrition
Added to basket
Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
The End of Your Life Book Club
Added to basket
The Emperor of All Maladies
Added to basket
Lecture Notes: Oncology
Added to basket
Medicine Hands
Added to basket
£29.99
Paperback
When I Die
Added to basket
£8.99
Paperback
Cancer Care
Added to basket
£7.99
Paperback
The Chemotherapy Survival Guide
Added to basket
Laws of Medicine
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£34.99
Part-work (fascículo)
Coping with Chemotherapy
Added to basket

Please sign in to write a review

Your review has been submitted successfully.